搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Pectobacterium carotovorum subsp. carotovorum 6-phosphofructokinase (pfkA) CSB-YP017822ESQ
CSB-EP017822ESQ
CSB-BP017822ESQ
CSB-MP017822ESQ
CSB-EP017822ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum ATP synthase subunit alpha (atpA), partial CSB-YP002344ESQ
CSB-EP002344ESQ
CSB-BP002344ESQ
CSB-MP002344ESQ
CSB-EP002344ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Cysteine desulfurase (sufS), partial CSB-YP015769ESQ
CSB-EP015769ESQ
CSB-BP015769ESQ
CSB-MP015769ESQ
CSB-EP015769ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Thymidylate kinase (tmk) CSB-YP007226ESQ
CSB-EP007226ESQ
CSB-BP007226ESQ
CSB-MP007226ESQ
CSB-EP007226ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Lipoyl synthase (lipA) CSB-YP012927GFR
CSB-EP012927GFR
CSB-BP012927GFR
CSB-MP012927GFR
CSB-EP012927GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Translation initiation factor IF-2 (infB), partial CSB-YP015164GFR
CSB-EP015164GFR
CSB-BP015164GFR
CSB-MP015164GFR
CSB-EP015164GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Malate dehydrogenase (mdh) CSB-YP013623GFR
CSB-EP013623GFR
CSB-BP013623GFR
CSB-MP013623GFR
CSB-EP013623GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Flap endonuclease 1 (FEN1) CSB-YP008585AZA
CSB-EP008585AZA
CSB-BP008585AZA
CSB-MP008585AZA
CSB-EP008585AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesocricetus auratus Probable polyprenol reductase (Srd5a3), partial CSB-YP022655MRG1
CSB-EP022655MRG1
CSB-BP022655MRG1
CSB-MP022655MRG1
CSB-EP022655MRG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nectria haematococca Methylthioribose-1-phosphate isomerase (MRI1) CSB-YP014799NFS
CSB-EP014799NFS
CSB-BP014799NFS
CSB-MP014799NFS
CSB-EP014799NFS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pteropus giganteus Hemoglobin subunit beta (HBB) CSB-YP010150FHG
CSB-EP010150FHG
CSB-BP010150FHG
CSB-MP010150FHG
CSB-EP010150FHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Ubiquitin-like modifier-activating enzyme 5 (GF23479) CSB-YP025415DKY
CSB-EP025415DKY
CSB-BP025415DKY
CSB-MP025415DKY
CSB-EP025415DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocella paludicola FAD synthase (ribL) CSB-YP008710MRX
CSB-EP008710MRX
CSB-BP008710MRX
CSB-MP008710MRX
CSB-EP008710MRX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sordaria macrospora Enolase-phosphatase E1 (UTR4) CSB-YP007674FIM
CSB-EP007674FIM
CSB-BP007674FIM
CSB-MP007674FIM
CSB-EP007674FIM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca CST complex subunit STN1 (OBFC1) CSB-YP016248AYX
CSB-EP016248AYX
CSB-BP016248AYX
CSB-MP016248AYX
CSB-EP016248AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca Tudor domain-containing protein 5 (TDRD5), partial CSB-YP023358AYX
CSB-EP023358AYX
CSB-BP023358AYX
CSB-MP023358AYX
CSB-EP023358AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca RBPJ-interacting and tubulin-associated protein (RITA) CSB-YP003085AYX
CSB-EP003085AYX
CSB-BP003085AYX
CSB-MP003085AYX
CSB-EP003085AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca BRCA1-associated ATM activator 1 (BRAT1), partial CSB-YP004155AYX
CSB-EP004155AYX
CSB-BP004155AYX
CSB-MP004155AYX
CSB-EP004155AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Archaeoglobus profundus FAD synthase (ribL) CSB-YP008710DOD
CSB-EP008710DOD
CSB-BP008710DOD
CSB-MP008710DOD
CSB-EP008710DOD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Naegleria gruberi Methylthioribose-1-phosphate isomerase (NAEGRDRAFT_32363) CSB-YP014799NFF
CSB-EP014799NFF
CSB-BP014799NFF
CSB-MP014799NFF
CSB-EP014799NFF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>